Skip to main content

Table 3 eGFR (MDRD) and UACR category prevalence of CKD in T2DM a

From: Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging

GFR category, ml/min/1.73 m2(MDRD) Albuminuria category, mg/g
< 30 30-300 > 300 Rowc
N % (95% CI) N % (95% CI) N % (95% CI) N % (95% CI)
G1 ≥ 90 629b 22.9 (20.7-25.1) 239 7.4 (6.1-8.6) 46 1.2 (0.7-1.7) 914 31.4 (28.9-34.0)
G2 60-89 834b 32.1 (29.4-34.7) 305 9.8 (8.3-11.3) 97 2.7 (2.0-3.3) 1236 44.6 (41.7-47.5)
G3a 45-59 267 9.6 (8.2-11.0) 141 4.0 (3.0-4.9) 51 1.4 (0.8-1.9) 459 14.9 (13.2-16.6)
G3b 30-44 88 2.9 (2.2-3.7) 74 2.1 (1.5-2.6) 40 1.2 (0.7-1.7) 202 6.2 (5.1-7.2)
G4 15-29 15 0.4 (0.2-0.5) 32 1.2 (0.6-1.7) 35 1.0 (0.4-1.6) 82 2.5 (1.8-3.2)
G5 < 15 d 0.0 (0.0-0.0) d 0.0 (0.0-0.0) 20 0.4 (0.1-0.6) 22 0.5 (0.1-0.7)
Column N, % (95% CI) c 1834 67.8 (65.7-70.0) 792 24.4 (22.3-26.4) 289 7.8 (6.5-9.1) 2915 100 (N/A)
  1. aAge adjusted to 2012 NHIS diabetes population.
  2. bDoes not meet CKD criteria based on eGFR or albuminuria.
  3. c Sum of rows and columns may deviate due to rounding.
  4. dCell frequency suppressed when count < 3 to avoid potential identifiability and imprecision of estimates.